These findings held true even for patients with existing kidney impairment at baseline, suggesting GLP-1 therapy addresses a fundamental mechanism of renal disease rather than masking surface symptoms
This is the first time that GLP-1 receptor agonists have been shown to regulate alcohol metabolism in the liver, says principal investigator Wajahat Mehal, MD, professor of medicine (digestive diseases) at YSM
Corrective Timing Traditional facial rejuvenation is typically corrective, but GLP-1-related changes benefit dramatically from preventative interventions before or during weight loss rather than after changes have occurred
The lean mass concern is real and documented
This latest study adds to a growing body of data on the positive cardiovascular effects of GLP-1-RAs beyond their initial indications for diabetes and weight management
Psychiatry 52 , 924948 (2018)